Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
Oncotarget
|
November 13, 2018
Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines
Nachi Namatame, Naomi Tamaki, Yuya Yoshizawa, et al.
Cancer Research Communications
|
March 31, 2026
Cooperative roles of class IA PI3K isoforms in translocation-related sarcoma cell survival and proliferation
Sho Isoyama, Naomi Tamaki, Yutaka Noguchi, et al.
Science Signaling
|
November 12, 2024
Metabolically inducing defects in DNA repair sensitizes <i>BRCA</i>-wild-type cancer cells to replication stress
Kenji Watanabe, Tatsuro Yamamoto, Tomoko Fujita, et al.
ACS Chemical Biology
|
November 3, 2021
Identification of Dihydroorotate Dehydrogenase Inhibitors─Indoluidins─That Inhibit Cancer Cell Growth
Makoto Kawatani, Harumi Aono, Takeshi Shimizu, et al.
Oncotarget
|
February 9, 2018
Targeting the Golgi apparatus to overcome acquired resistance of non-small cell lung cancer cells to EGFR tyrosine kinase inhibitors
Yoshimi Ohashi, Mutsumi Okamura, Ryohei Katayama, et al.
Cancer Science
|
April 28, 2015
Comprehensive transcriptomic analysis of molecularly targeted drugs in cancer for target pathway evaluation
Tetsuo Mashima, Masaru Ushijima, Masaaki Matsuura, et al.
Oncology Research
|
September 25, 2023
Identification of a dihydroorotate dehydrogenase inhibitor that inhibits cancer cell growth by proteomic profiling
Makoto Kawatani, Harumi Aono, Sayoko Hiranuma, et al.
Bioorganic & Medicinal Chemistry
|
August 29, 2015
Ridaifen G, tamoxifen analog, is a potent anticancer drug working through a combinatorial association with multiple cellular factors
Kentaro Ikeda, Shinji Kamisuki, Shoko Uetake, et al.
Bioorganic & Medicinal Chemistry
|
December 20, 2020
(S)-Erypoegin K, an isoflavone isolated from Erythrina poeppigiana, is a novel inhibitor of topoisomerase IIα: Induction of G2 phase arrest in human gastric cancer cells
Kiyomi Hikita, Yuko Yamakage, Honoka Okunaga, et al.
Cancer Science
|
July 15, 2024
Cytochrome P450 2J2 is required for the natural compound austocystin D to elicit cancer cell toxicity
Yukiko Kojima, Saki Fujieda, Liya Zhou, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
Oncotarget
|
November 13, 2018
Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines
Nachi Namatame, Naomi Tamaki, Yuya Yoshizawa, et al.
Cancer Research Communications
|
March 31, 2026
Cooperative roles of class IA PI3K isoforms in translocation-related sarcoma cell survival and proliferation
Sho Isoyama, Naomi Tamaki, Yutaka Noguchi, et al.
Science Signaling
|
November 12, 2024
Metabolically inducing defects in DNA repair sensitizes <i>BRCA</i>-wild-type cancer cells to replication stress
Kenji Watanabe, Tatsuro Yamamoto, Tomoko Fujita, et al.
ACS Chemical Biology
|
November 3, 2021
Identification of Dihydroorotate Dehydrogenase Inhibitors─Indoluidins─That Inhibit Cancer Cell Growth
Makoto Kawatani, Harumi Aono, Takeshi Shimizu, et al.
Oncotarget
|
February 9, 2018
Targeting the Golgi apparatus to overcome acquired resistance of non-small cell lung cancer cells to EGFR tyrosine kinase inhibitors
Yoshimi Ohashi, Mutsumi Okamura, Ryohei Katayama, et al.
Cancer Science
|
April 28, 2015
Comprehensive transcriptomic analysis of molecularly targeted drugs in cancer for target pathway evaluation
Tetsuo Mashima, Masaru Ushijima, Masaaki Matsuura, et al.
Oncology Research
|
September 25, 2023
Identification of a dihydroorotate dehydrogenase inhibitor that inhibits cancer cell growth by proteomic profiling
Makoto Kawatani, Harumi Aono, Sayoko Hiranuma, et al.
Bioorganic & Medicinal Chemistry
|
August 29, 2015
Ridaifen G, tamoxifen analog, is a potent anticancer drug working through a combinatorial association with multiple cellular factors
Kentaro Ikeda, Shinji Kamisuki, Shoko Uetake, et al.
Bioorganic & Medicinal Chemistry
|
December 20, 2020
(S)-Erypoegin K, an isoflavone isolated from Erythrina poeppigiana, is a novel inhibitor of topoisomerase IIα: Induction of G2 phase arrest in human gastric cancer cells
Kiyomi Hikita, Yuko Yamakage, Honoka Okunaga, et al.
Cancer Science
|
July 15, 2024
Cytochrome P450 2J2 is required for the natural compound austocystin D to elicit cancer cell toxicity
Yukiko Kojima, Saki Fujieda, Liya Zhou, et al.
Page
of 9